Cowan A, Watson T
Psychopharmacology (Berl). 1978 Apr 14;57(1):43-6. doi: 10.1007/BF00426956.
Thyrotropin-releasing hormone (TRH), sodium valproate, AF-3-5 (1-[2-hydroxyphenyl]-4-[3-nitrophenyl]-1,2,3,6-tetrahydropyrimidine-2-one), RX336-M (7,8-dihydro-5',6'-dimethylcyclohex-5'-eno-1',2',8',14 codeinone), and Sgd 8473 (alpha-[4-chlorobenzylideneamino)-oxy]-isobutyric acid) each induced repetitive shaking of the body of rats after intraperitoneal injection. This action of the five diverse chemicals appears to be subserved by a common pharmacological component, because pretreatment with d-lysergic acid diethylamide (0.03--1.0 mg kg-1, s.c.) attenuated the shaking behavior in a dose-related manner, and cross tolerance was found between RX336-M and TRH, sodium valproate, and AG-3-5.
促甲状腺激素释放激素(TRH)、丙戊酸钠、AF - 3 - 5(1 - [2 - 羟基苯基] - 4 - [3 - 硝基苯基] - 1,2,3,6 - 四氢嘧啶 - 2 - 酮)、RX336 - M(7,8 - 二氢 - 5',6' - 二甲基环己 - 5' - 烯 - 1',2',8',14 - 可待因酮)和Sgd 8473(α - [4 - 氯亚苄基氨基)- 氧基] - 异丁酸)腹腔注射后均能诱导大鼠身体出现重复性颤抖。这五种不同化学物质的这种作用似乎由一种共同的药理学成分介导,因为用d - 麦角酸二乙酰胺(0.03 - 1.0毫克/千克,皮下注射)预处理会以剂量相关的方式减弱颤抖行为,并且在RX336 - M与TRH、丙戊酸钠和AG - 3 - 5之间发现了交叉耐受性。